These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


165 related items for PubMed ID: 9784312

  • 1. Prognostic significance of DNA content and S-phase fraction in epithelial ovarian carcinomas analyzed by image cytometry.
    Reles AE, Gee C, Schellschmidt I, Schmider A, Unger M, Friedmann W, Lichtenegger W, Press MF.
    Gynecol Oncol; 1998 Oct; 71(1):3-13. PubMed ID: 9784312
    [Abstract] [Full Text] [Related]

  • 2. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS, Gersell DJ, Yim S.
    Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
    [Abstract] [Full Text] [Related]

  • 3. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R, Wimberger P, Hillemanns P, Kapsner T, Caspari C, Hepp H.
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [Abstract] [Full Text] [Related]

  • 4. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L, Bouchet C, Cesari D, Uzan S, Lefranc JP, Antoine M, Genestie C, Deniaud-Alexandre E, Bernaudin JF, Touboul E, Fleury-Feith J.
    Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
    [Abstract] [Full Text] [Related]

  • 5. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
    Dolan JR, McCall AR, Gooneratne S, Walter S, Lansky DM.
    Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
    [Abstract] [Full Text] [Related]

  • 6. Influence of cellular DNA content on survival in ovarian carcinoma.
    Klemi PJ, Joensuu H, Mäenpää J, Kiilholma P.
    Obstet Gynecol; 1989 Aug; 74(2):200-4. PubMed ID: 2748056
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma.
    Pfisterer J, Kommoss F, Sauerbrei W, Rendl I, Kiechle M, Kleine W, Pfleiderer A.
    Gynecol Oncol; 1995 Aug; 58(2):149-56. PubMed ID: 7622098
    [Abstract] [Full Text] [Related]

  • 8. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
    Veerman MM, van der Wurff AA, van de Water M, Kruitwagen RF, Feijen HW, Vos MC.
    Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ovarian tumors of low malignant potential. Correlation of DNA index and S-phase fraction with histopathologic grade and clinical outcome.
    Demirel D, Laucirica R, Fishman A, Owens RG, Grey MM, Kaplan AL, Ramzy I.
    Cancer; 1996 Apr 15; 77(8):1494-500. PubMed ID: 8608534
    [Abstract] [Full Text] [Related]

  • 13. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L, Bouchet C, Cesari D, Uzan S, Lefranc JP, Antoine M, Genestie C, Deniaud-Alexandre E, Bernaudin JF, Touboul E, Fleury-Feith J.
    Cancer Radiother; 2005 Dec 15; 9(8):575-86. PubMed ID: 16243560
    [Abstract] [Full Text] [Related]

  • 14. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
    Salvesen HB, Iversen OE, Akslen LA.
    Clin Cancer Res; 1998 Nov 15; 4(11):2779-85. PubMed ID: 9829742
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of nuclear DNA quantification and cyclin A expression in epithelial ovarian carcinoma.
    Yoon BS, Kim YT, Kim S, Lee CS, Kim JW, Kim JH, Kim SW, Cho NH.
    Eur J Obstet Gynecol Reprod Biol; 2008 Jan 15; 136(1):110-5. PubMed ID: 17157431
    [Abstract] [Full Text] [Related]

  • 16. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
    Gazic B, Pizem J, Bracko M, Cufer T, Borstnar S, Pohar-Marinsek Z, Us-Krasovec M.
    Cytopathology; 2008 Oct 15; 19(5):294-302. PubMed ID: 18070112
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. DNA content of nasopharyngeal carcinoma: an independent prognostic indicator.
    Hsu MM, Chiou CR, Ko JY, Sheen TS, Hong RL, Ting LL.
    Cancer Detect Prev; 2000 Oct 15; 24(2):119-26. PubMed ID: 10917131
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Prognostic significance of cellular DNA content and AgNOR count in ovarian cystadenoma].
    Lu XL, Yi WM, Wang LF.
    Ai Zheng; 2003 Jan 15; 22(1):62-5. PubMed ID: 12561439
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.